🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Registered Cohort Study on FSHD1

Recruitingn/aAges any - anyAllNing Wang, MD., PhD.
NCT04369209 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and natural history of FSHD1.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male or female subjects of all ages at baseline * Subjects, with or without symptoms, with FSHD1 genetic confirmation through PFGE-based Southern blotting * Unrelated healthy controls Exclusion Criteria: * Decline to participate * Other neuromuscular disease (such as Limb-girdle muscular dystrophy or Myotonic dystrophy) * Serious systemic illness (such as heart, liver, kidney disease or major mental illness)
💊

What it tests

  • Not listed
📍

Where

1 site
First Affiliated Hospital of Fujian Medical University
Fuzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy